2seventy bio (TSVT) Earnings Date & Reports

2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TSVT is expected to report earnings to fall 1,600.00% to -15 cents per share on August 06

2seventy bio TSVT Stock Earnings Reports

Q2'25

Est.

$-0.15

Q1'25

Beat

by $0.18

Q4'24

Missed

by $0.17

Q3'24

Est.

$-0.19

Q2'24

Beat

by $1.21

The last earnings report on May 07 showed earnings per share of 0 cents, beating the estimate of -17 cents. With 347.59K shares outstanding, the current market capitalization sits at 266.14M.

View a ticker or compare two or three

Compare

TSVT